Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.5940.03-17.601.8437.90

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 17.59 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹63,427.5 Cr 1.6% -2.8% 9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹98,795.9 Cr -1.1% -6.3% -18.3% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

1.6%

-2.8%

9.4%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses